Clinical Trial

Optimal Time Interval Between Mifepristone and Misoprostol Administration for Early Pregnancy Loss

Name: Optimal Time Interval Between Mifepristone and Misoprostol Administration for Early Pregnancy Loss — clinical trial record (NCT07506512)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TIME

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

A prospective cohort study to explore the optimal time interval between mifepristone and misoprostol administration for medical management of early pregnancy loss. Participants will be followed to assess treatment success, satisfaction, and side effects.

Trial Details

NCT Number	NCT07506512
Lead Sponsor	University of Pennsylvania
Conditions	Early Pregnancy Loss
Enrollment	1,000 participants
Start Date	2026-07
Primary Completion	2031-07 (estimated)
Study Completion	2031-12 (estimated)
Updated on ClinicalTrials.gov	2026-04-01